These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3931468)

  • 1. Releasable vascular plasminogen activator and thrombotic strokes.
    Pizzo SV; Petruska DB; Doman KA; Soong SJ; Fuchs HE
    Am J Med; 1985 Oct; 79(4):407-11. PubMed ID: 3931468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective release of vascular plasminogen activator in patients with gynecologic malignancies.
    Doman KA; Gore M; Miller KE; Soong SJ; Clarke-Pearson DL; Pizzo SV
    Gynecol Oncol; 1986 Feb; 23(2):141-8. PubMed ID: 3080356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous and arterial thromboembolic disease in women using oral contraceptives.
    Miller KE; Pizzo SV
    Am J Obstet Gynecol; 1982 Dec; 144(7):824-7. PubMed ID: 6890768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of endogenous tissue plasminogen activator and risk of stroke.
    Ridker PM; Hennekens CH; Stampfer MJ; Manson JE; Vaughan DE
    Lancet; 1994 Apr; 343(8903):940-3. PubMed ID: 7909008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenteric vein thrombosis and vascular plasminogen activator.
    Boyko OB; Pizzo SV
    Arch Pathol Lab Med; 1983 Oct; 107(10):541-2. PubMed ID: 6688517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.
    Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH
    Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis.
    Jordan JM; Allen NB; Pizzo SV
    Am J Med; 1987 Mar; 82(3):397-400. PubMed ID: 3103439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis.
    Pizzo SV; Fuchs HE; Doman KA; Petruska DB; Berger H
    Arch Intern Med; 1986 Jan; 146(1):188-91. PubMed ID: 2935105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.
    Violi F; Ferro D; Valesini G; Quintarelli C; Saliola M; Grandilli MA; Balsano F
    BMJ; 1990 Apr; 300(6732):1099-102. PubMed ID: 2111722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alterations of fibrinolysis in stroke].
    Hernández Nuñez A; Romero Barbero JL; Cáceres Sansaloni A; Pérez de Oteyza C
    An Med Interna; 1996 Mar; 13(3):107-10. PubMed ID: 8679836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic imbalance in essential thrombocythemia: role of platelets.
    Bazzan M; Tamponi G; Gallo E; Stella S; Schinco PC; Pannocchia A; Pileri A
    Haemostasis; 1993; 23(1):38-44. PubMed ID: 8477907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasminogen activator inhibitor levels found in patients with malignant conditions.
    Newland JR; Haire WD
    Am J Clin Pathol; 1991 Nov; 96(5):602-4. PubMed ID: 1951185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
    Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS
    Thromb Haemost; 1991 Nov; 66(5):581-5. PubMed ID: 1803623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular plasminogen activator levels and thromboembolic disease in patients with gynecologic malignancies.
    Gore M; Miller KE; Soong SJ; Clarke-Pearson DL; Pizzo SV
    Am J Obstet Gynecol; 1984 Aug; 149(8):830-4. PubMed ID: 6540521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation.
    Kahn SR; Solymoss S; Flegel KM
    CMAJ; 1997 Sep; 157(6):685-9. PubMed ID: 9307554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue-type plasminogen activator--biochemistry, physiology and clinical use].
    Gmiński J; Flak A
    Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1055-9. PubMed ID: 2517807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolytic activity in laparoscopic cholecystectomy.
    Martinez-Ramos C; Lopez-Pastor A; Núñez-Peña JR; Ruiz-Caravaca ML; Ruiz de Gopegui M; Sanz-López R; Jorgensen TW; Tamames-Escobar S
    J Laparoendosc Adv Surg Tech A; 1998 Dec; 8(6):417-23. PubMed ID: 9916595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
    Mansfield MW; Catto AJ; Carter AM; Grant PJ
    Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.